Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PYCR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MAFG-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MYADML2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAFG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIRT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOTUM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCYT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANAPC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALYREF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASPSCR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STRA13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCXR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFNG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on